Variable ABO-matched Major MM Minor MM Bi-Dir MM P
Patients, n 38 (44.7%) 17 (20.0%) 21 (24.7%) 9 (10.6%)
Age, years (median ± SD)
6.73 ± 3.3
7.58 ± 3.75
5.8 ± 3.82
6.77 ± 4.41
0.521
Sex 0.674
Male/female 22/16 8/9 9/12 4/5
Disease classification 0.132
SAA 25 (65.8%) 10 (58.8%) 16 (76.2%) 9 (100.0%)
VSAA 13 (34.2%) 7 (41.2%) 5 (23.8%) 0 (0.0%)
Donor type 0.690
HID 16 (42.1%) 10 (58.8%) 11 (52.4%) 4 (44.4%)
MSD 6 (15.8%) 1 (5.9%) 3 (14.3%) 0 (0.0%)
UD 16 (42.1%) 6 (35.3%) 7 (33.3%) 5 (55.6%)
Ferr (range) 849.4 (627.1–1071.7) 2195.0 (-1085.8 to 5475.8) 1377.9 (494.2–2261.6) 741.1 (394.9–1087.2) 0.701
MNC, ×108/L (median ± SD) 8.2 ± 1.2 8.5 ± 3.5 8.7 ± 1.5 8.3 ± 1.3 0.844
CD34, ×106/L (median ± SD) 6.0 ± 2.6 5.7 ± 2.5 5.3 ± 2.2 4.3 ± 1.0 0.281
Neutrophil engraftment 13.0 (12.9–14.7) 12.0 (12.4–15.0) 13.0 (12.3–15.6) 13.0 (11.8–14.0) 0.896
Platelet
engraftment
16.2 ± 5.7
16.2 ± 6.0
16.6 ± 5.6
14.3 ± 3.2
0.785
aGVHD classification 15 (39.5%) 3 (17.7%) 5 (23.8%) 1 (11.1%) 0.186
cGVHD classification 5 (13.2%) 2 (11.76%) 5 (23.81%) 1 (11.1%) 0.740
Follow-up period, months 30.2 ± 23.4 30.9 ± 22.2 32.6 ± 14.0 38.7 ± 19.5 0.529